Inventor · disambiguated record
Rebecca Taub
Also filed as: TAUB REBECCA · TAUB REBECCA A · TAUB REBECCA ANNE
9 granted patents·7 pending applications·32 citations·filing 1988–2025
85Inventor score
Files withMADRIGAL PHARMACEUTICALS INC10TAUB REBECCA2CONDE-KNAPE KARIN1HOFFMANN LA ROCHE1TALLIKUT PHARMACEUTICALS INC1
Top patents by PatentIndex Score
16 records- 0195US10376517B2Methods of synthesizing thyroid hormone analogs and polymorphs thereofMADRIGAL PHARMACEUTICALS INC·Filed 2018·Granted Aug 13, 2019·9 cites·25 claims
- 0294US9968612B2Method of synthesizing thyroid hormone analogs and polymorphs thereofMADRIGAL PHARMACEUTICALS INC·Filed 2016·Granted May 15, 2018·9 cites·18 claims
- 0392US11806353B2Methods of treating liver disorders or lipid disorders with a THR-beta agonistMADRIGAL PHARMACEUTICALS INC·Filed 2021·Granted Nov 7, 2023·2 cites·17 claims
- 0486US11986481B2Method of synthesizing thyroid hormone analogs and polymorphs thereofMADRIGAL PHARMACEUTICALS INC·Filed 2023·Granted May 21, 2024·0 cites·18 claims
- 0585US11090308B2Methods of treating liver disorders or lipid disorders with a THR-beta agonistMADRIGAL PHARMACEUTICALS INC·Filed 2017·Granted Aug 17, 2021·5 cites·11 claims
- 0677US7642244B2Neuropeptide-2 receptor (Y-2R) agonists and uses thereofHOFFMANN LA ROCHE·Filed 2006·Granted Jan 5, 2010·4 cites·18 claims
- 0776US2024156826A1Methods of treating liver disorders or lipid disorders with a thr-beta agonistMADRIGAL PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0866US2024408102A1Resmetirom for reducing liver volumeMADRIGAL PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0965US2024423992A1Biomarkers for treating liver disorders with thr-b agonists and related usesMADRIGAL PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1059US12377104B1Methods for treating a fatty liver diseaseMADRIGAL PHARMACEUTICALS INC·Filed 2025·Granted Aug 5, 2025·0 cites·24 claims
- 1157US2024307405A1Therapeutic combinations of rosuvastatin and resmetirom for the treatment of liver disorders or lipid disordersMADRIGAL PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1255US8268784B2Neuropeptide-2 receptor (Y-2R) agonists and uses thereofCONDE-KNAPE KARIN·Filed 2009·Granted Sep 18, 2012·0 cites·3 claims
- 1342US2013317078A1Phenylalkyl n-hydroxyureas for treating leukotriene related pathologiesTALLIKUT PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 1436US2012029048A1Phenylalkyl n-hydroxyureas for treating leukotriene related pathologiesTAUB REBECCA·Filed 2011·Application pending·0 cites
- 1532US5169836AInhibitors of platelet bindingUNIV PENNSYLVANIA·Filed 1988·Granted Dec 8, 1992·3 cites·6 claims
- 1631US2013190514A1Phenylalkyl n-hydroxyureas for treating leukotriene related pathologiesTAUB REBECCA·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →